entertainment -WSS

entertainment

author：explore 2025-10-01 00:58:44 - browse：8

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Deposition: Sackler embraced plan to conceal OxyContin’s strength

focus

WSS

Lilly's Alzheimer's drug donanemab backed by FDA advisers

NIH tests clinical research in primary care with $30 million program

STAT Virtual Event: ASCO Recap, Live!

The system is set up to fail children with medical complexity

Medicare says breakthrough device reimbursement rule to come by summer

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Wikipedia

entertainment

focus

Jerome Adams on the need for new antivirals for Covid

Researchers on aging grapple with how to calculate biological age

Anesthesiologist group: stop taking Ozempic before surgery

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Medical leaders decry Supreme Court decision on affirmative action

Dairy farmers resist CDC push for PPE against bird flu virus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

First recipient of genetically engineered pig kidney has died

Sports medicine is finally prioritizing gender equality

Moderna says combo Covid

hotspot

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Google says AlphaFold 3 can map a vast universe of biomolecules

Lilly's Alzheimer's drug donanemab backed by FDA advisers

How to improve immunocompromised access to mAb treatments

Study: Adult vaccinations pay for themselves in societal benefits

Brain worms: The science behind RFK Jr.'s parasitic infection

entertainment

entertainment

focus

entertainment